1. Home
  2. CPRX vs APAM Comparison

CPRX vs APAM Comparison

Compare CPRX & APAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPRX
  • APAM
  • Stock Information
  • Founded
  • CPRX 2002
  • APAM 1994
  • Country
  • CPRX United States
  • APAM United States
  • Employees
  • CPRX N/A
  • APAM N/A
  • Industry
  • CPRX Biotechnology: Pharmaceutical Preparations
  • APAM Investment Managers
  • Sector
  • CPRX Health Care
  • APAM Finance
  • Exchange
  • CPRX Nasdaq
  • APAM Nasdaq
  • Market Cap
  • CPRX 2.8B
  • APAM 2.5B
  • IPO Year
  • CPRX 2006
  • APAM 2013
  • Fundamental
  • Price
  • CPRX $22.52
  • APAM $35.04
  • Analyst Decision
  • CPRX Strong Buy
  • APAM Hold
  • Analyst Count
  • CPRX 7
  • APAM 5
  • Target Price
  • CPRX $32.29
  • APAM $40.30
  • AVG Volume (30 Days)
  • CPRX 1.7M
  • APAM 667.1K
  • Earning Date
  • CPRX 05-07-2025
  • APAM 04-29-2025
  • Dividend Yield
  • CPRX N/A
  • APAM 9.90%
  • EPS Growth
  • CPRX 107.94
  • APAM 14.69
  • EPS
  • CPRX 1.31
  • APAM 3.66
  • Revenue
  • CPRX $491,734,000.00
  • APAM $1,111,802,000.00
  • Revenue This Year
  • CPRX $15.17
  • APAM $7.39
  • Revenue Next Year
  • CPRX $9.61
  • APAM $7.04
  • P/E Ratio
  • CPRX $17.19
  • APAM $9.58
  • Revenue Growth
  • CPRX 23.49
  • APAM 14.02
  • 52 Week Low
  • CPRX $14.47
  • APAM $32.75
  • 52 Week High
  • CPRX $26.16
  • APAM $49.54
  • Technical
  • Relative Strength Index (RSI)
  • CPRX 48.15
  • APAM 37.63
  • Support Level
  • CPRX $21.93
  • APAM $34.61
  • Resistance Level
  • CPRX $23.27
  • APAM $36.30
  • Average True Range (ATR)
  • CPRX 1.27
  • APAM 1.96
  • MACD
  • CPRX -0.14
  • APAM -0.10
  • Stochastic Oscillator
  • CPRX 50.60
  • APAM 29.43

About CPRX Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).

About APAM Artisan Partners Asset Management Inc.

Artisan Partners Asset Management Inc is a global investment management firm providing a range of investment strategies to a diverse group of clients around the world. Each of the company's strategies is managed by one of its several investment teams. Investment management services are primarily offered to institutions through separate accounts and mutual funds. Artisan's investment offerings include several long-only, equity investment strategies across a multitude of market capitalization segments and investing styles in both the United States and international markets. In addition to its equity strategies, customers may invest in a fixed-income strategy. Strategies are often distributed to customers ranging from retail investors to institutional investors through specialized channels.

Share on Social Networks: